H&Q Life Sciences Investors (NYSE: HQL) is a diversified closed-end fund. The Fund’s investment objective is long-term capital appreciation through investment in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. George Silva of […]